Remove tag litigation
article thumbnail

A history of Johnson & Johnson

pharmaphorum

Litigation & controversy. Beginning in 2003, J&J became involved in a series of litigations with Boston Scientific involving patents covering heart stent medical devices. The litigation was settled in 2009, when Boston Scientific agreed to pay $716 million in September and an additional $1.73

Sales 126
article thumbnail

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

GAAP net income and its components and diluted EPS (1). (3) healthcare reform or legislation or any significant spending reductions or cost controls affecting Medicare, Medicaid or other publicly funded or subsidized health programs or changes in the tax treatment of employer-sponsored health insurance that may be implemented; U.S. Source link.